US Medical Sensors, as a subdivision of US Nuclear Corp, through its strategic partnership with MIFTEC, a division of Magneto-Inertial Fusion Technologies, Inc. (MIFTI), is posed to produce medical isotopes through fusion power instead of the risky fission power currently utilized. This process will produce isotopes for accurate diagnostic scans and cancer treatment at a fraction of the cost and production time as currently produced medical isotopes.
US Nuclear Corp’s strategic partnership with MIFTEC provides exclusive manufacturing and sales rights for the medical isotope fusion generators in North America and Asia.
Radioactive isotopes are used in nuclear medicine to image, diagnose, and treat.
Radiopharmacies are increasing with new and innovative treatments utilizing isotopes. Hospital populations are among the most vulnerable to radiation leaks or outside intrusions.
- Critical Healthcare Problem
- Worldwide Shortage of Medical Isotopes
- Nuclear Medicine, Imagining, Diagnosis, Treatment
- Global radioisotope market demand: $10 billion today
- Expected to reach $17 billion by 2021
- About 80% of this is for diagnostic medicine
- North America is the dominant market for radioisotopes; close to half of the market share,
- Europe accounts for about 20%.
- ABUNDANT AND UNLIMITED FUEL SUPPLY. The fuel used by MIF in a Staged Z-pinch is extracted from seawater. This means that there is an infinite supply of fuel.
- NO NUCLEAR WASTE. Contrary to a conventional nuclear reactor based on a fission process where the storage of nuclear waste will continue to be a major challenge, a fusion reactor using the MIF in a Staged Z-pinch concept would have little, or no, nuclear waste to store underground for hundreds of thousands of years.
There are two main uses for medical isotopes: diagnosis and treatment. Diagnostic procedures using radioisotopes are now routine and can be used to examine blood flow to the brain, the functioning of the liver, lungs, heart, or kidneys—the advantage over other techniques being that you can image both bone and soft tissue, and assess what is happening physiologically. The most prominent treatment application is for cancer, using radiation to weaken or destroy targeted cancer cells.
There are no effective suppliers of medical isotopes in the USA and existing international suppliers cannot expand because of prohibitive costs and pollution problems. All new/existing competitors in the market rely on fission/cyclotrons/accelerators to produce the isotopes, which all require enriched uranium as a fuel supply, cost hundreds of millions of dollars to build, and could take up to 10 years or more to commission. This has resulted in a desperate shortage of radioisotopes and a huge unfilled demand.
MIFTEC’s fusion approach for generating medical isotopes uses heavy seawater for an unlimited fuel supply and poses no serious radiation issues. The design is extremely small compared to other methods, and could easily be placed at hospitals and medical facilities around the world. With rapid production at 50% of the current cost, many more patients will have the opportunity to receive these critical diagnostic scans and treatment, thereby saving hundreds of thousands of additional lives.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .